Background: Enterovirus 71 (EV71) is the main pathogen that causes severe hand, foot, and mouth disease with fatal neurological complications. However, its neurovirulence mechanism is still unclear. Candidate virulence sites were screened out at structural protein VP1, but the function of these candidate virulence sites remains unclear. Several studies have shown that autophagy is associated with viral replication. However, the relationship between VP1 and autophagy in human neurons has not been studied. Methods: A recombinant virus-SDLY107-VP1, obtained by replacing the VP1 full-length gene of the SDLY107 strain with the VP1 full-length gene of the attenuated strain SDJN2015-01-was constructed and tested for replication and virulence. We then tested the effect of the recombinant virus on autophagy in nerve cells. The effect of autophagy on virus replication was detected by western blot and plaque test. Finally, the changes of mTOR signaling molecules during EV71 infection and the effect of mTOR on virus replication at the RNA level were detected. Results: Viral recombination triggered virulence attenuation. The replication ability of recombinant virus SDLY107-VP1 was significantly weaker than that of the parent strain SDLY107. The SDLY107 strain could inhibit autophagic flux and led to accumulation of autophagosomes, while the SDLY107-VP1 strain could not cause autophagosome accumulation. The synthesis of EV71 RNA was inhibited by inhibiting mTOR. Conclusions: Replacement of VP1 weakened the replication ability of virulent strains and reduced the level of autophagy in nerve cells. This autophagy facilitates the replication of virulent strains in nerve cells. VP1 is an important neurovirulence determinant of EV71, which affects virus replication by regulating cell autophagy. mTOR is a key molecule in this type of autophagy. [3] [4] [5] [6] [7] [8] .
Introduction
Enterovirus 71 (EV71), which belongs to the Picornaviridae family, is an icosahedral non-enveloped single-stranded RNA virus and is the second most important neurotropic enterovirus [1] . It causes hand, foot, and mouth disease (HFMD), which occurs mainly in young children below 4 years of age and usually presents as a self-limiting, mild febrile disease with symptoms including ulcers in the mouth, maculopapular rashes, or blister-like eruptions on the palms and soles [2] . EV71 has been increasingly associated with neurological disorders that range from aseptic meningitis with or without pulmonary edema to brain stem encephalitis and poliomyelitis-like acute flaccid paralysis, particularly
Materials and Methods

Antibodies and Chemical Reagents
The antibodies used in the study were anti-LC3B (Boston, USA, Cell Signaling Technology, Cat#2775), anti-p62 (Cambridge, UK, Abcam, 56416), anti-enterovirus 71 (Abcam 169442), anti-βactin (Beijing, China, ZSGB-BIO), anti-GAPDH (Wuhan, China, Proteintech, 60004), anti-mTOR (Cell Signaling Technology Cat#2983), anti-phospho-mTOR (Boston, USA, Cell Signaling Technology, Cat#5536), FICT-conjugated Affinipure Goat Anti-Mouse IgG (ZSGB-BIO), HPR-conjugated Affinipure Goat Anti-Rabbit IgG (Proteintech, SA-00001-2), and HPR-conjugated Affinipure Goat Anti-Mouse IgG (Proteintech, SA-00001-1). The anti-EV71 antibody used in the immunofluorescent assay was a mouse-derived polyclonal antibody made by our group [24] . Chemical reagents used in the study were rapamycin (Sigma, Germany, V900930), 3-Methyladenine (3-MA, Sigma, M9281) and chloroquine (CQ, Sigma, C6628).
Cell Lines and Viruses
Rhabdomyosarcoma (RD) cells were provided by the Shandong Center for Disease Control (Purchased from ATCC, USA) and cultured in minimum essential medium (MEM, USA, Gibco) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Gibco) at 37 • C in the presence of 5% CO 2 . Human neuroblastoma (SH-SY5Y) cells provided by the Department of Biochemistry and Molecular Biology, School of Basic Medicine, Shandong University (Purchased from ATCC, USA) were cultured in MEM medium (Gibco) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Gibco) at 37 • C in the presence of 5 % CO 2 . The severe EV71 strain SDLY107 was isolated from a fatal case of HFMD from Linyi City, Shandong Province, China in 2011 [25] . In vivo and in vitro experiments showed that this strain has faster replication and stronger pathogenicity compared to strains isolated from patients with a mild illness [26, 27] . The full-length infectious cDNA clones of the SDLY107 strain (SDLY107 RV ) were successfully constructed using reverse genetics technology, and no significant differences in biological characteristics were observed between wild-type SDLY107 and rescued SDLY107 RV [28] . The mild EV71 strain SDJN2015-01 was isolated from a child with mild hand, foot, and mouth disease and no neurological complications. The recombinant EV71 virus SDLY107-VP1 was rescued by chimeric infectious clone pMD19T-107-VP1, which was constructed by replacing the VP1 full-length fragment of SDLY107 with the VP1 gene of SDJN2015-01. The target fragment to be replaced was amplified by PCR and ligated to the vector to obtain a recombinant plasmid containing the DNA fragment of the VP1 sequence of the SDJN2015-01 strain. The recombinant plasmid and the full-length plasmid of pMD-19T-107 preserved in the laboratory were identified by restriction endonuclease Nru I and BsiW I for restriction endonuclease digestion. The DNA fragment containing the VP1 sequence of the SDJN2015-01 strain and the DNA fragment of the remaining sequence of the SDLY107 strain except the VP1 sequence were then recovered. The recovered products were transformed after T4 connection to obtain a full-length DNA fragment of SDLY107-VP1, which was identified and subjected to in vitro transcription to obtain the RNA of SDLY107-VP1. All strains were propagated in RD cells in MEM supplemented with 1% FBS. The virus titer was routinely determined by plaque assay. The virus suspension of different dilutions was inoculated on RD monolayer cells to make the virus adsorb onto the cells, and then covered with a layer of nutrient methylcellulose culture medium. When there was no new plaque, crystal violet fuel was added. Because dead cells cannot uptake crystal violet fuel, the associated plaque will be unstained. In theory, a plaque is formed by infection of a virus particle. The plaque morphology was observed and the number of plaques was counted and multiplied with the dilution multiple to get the virus titer.
Virus Infection
SH-SY5Y cells were infected with SDLY107, SDJIN2015-01, and SDLY107-VP1 at a multiplicity of infection (MOI) of 1. They were then replenished with fresh MEM containing 1% FBS, which was Viruses 2020, 12, 11 4 of 14 used for the sham group after washing with PBS. For experiments that added inhibitors, cells were pre-treated with the inhibitors (dissolved in MEM or DMSO) for 2 h before viral infection. They were then washed with PBS and infected with the virus for 1 h, and fresh MEM containing 1% FBS for the sham group.
Replication Kinetics
SH-SY5Y cells and RD cells were seeded at a density of 2 × 10 5 cells per mL in 12 well plates and, when SH-SY5Y reached 70%-80% percent confluence, cells were infected with EV71 strains at MOI = 1. The cells and culture supernatant were sampled together every 12 h post infection. The corresponding viral load at 0 h was the amount of RNA in the prepared virus suspension. Total viral RNA was extracted using an RNA extraction kit (E.Z.N.A. ® Viral RNA Kit, OMEGA, Guangzhou, China) according to the manufacturer's instructions. The replication kinetics of SDLY107, SDLY107-VP1, and SDJN2015-01 were determined by real-time quantitative PCR (qRT-PCR) as described in a previous study [29] . Experiments were performed in triplicate, with three repeats for each experiment.
Lactate Dehydrogenase (LDH) Cytotoxicity Assay
SH-SY5Y cells were seeded at a density of 2 × 10 5 cells per mL in 12 well plates and, when SH-SY5Y reached 70%-80% percent confluence, cells were infected with EV71 strains at MOI = 1. LDH activity was detected using a Cytotoxicity Assay Kit (Shanghai, China, Beyotime,) according to the manufacturer's protocol. The rate of cell injury was calculated by LDH content as follows: Rate of cell injury (%) = absorbance of treatment group − absorbance of control group absorbance of maximum enzyme activity group − absorbance of control group . Experiments were performed in triplicate, with three repeats for each experiment.
Drugs Used to Induce or Inhibit Autophagy
A measure of 3-MA (50 µM, dissolved in MEM) was used to inhibit the early stage of autophagy. CQ (20 µM, dissolved in MEM) was used to inhibit autophagosome degradation, and rapamycin (10 nM, dissolved in DMSO) was used to promote degradation of autolysosome. Two h later, cells were washed three times and infected with the three strains of the virus. MEM containing 1% FBS was used for the sham group.
Detection of Autophagosomes, Viruses, and mTOR in Cells by Immunofluorescent Assay
SH-SY5Y cells were seeded on glass coverslips at 70%-80%confluency and infected with EV71. The cells were fixed in 4% paraformaldehyde for 10 min at room temperature, and blocked with 5% bovine serum albumin in 0.1% Triton X-100 (diluted in PBS) for 2 h, followed by incubation with the primary antibody overnight at 4 • C. After washing three times, the samples were incubated with secondary antibodies for 60 min, and observed under a fluorescent microscope after three washes. Autophagosomes were detected using the CYTO-ID ® Autophagy Detection kit (New York, USA, Enzo) in strict accordance with the instructions. The images were captured using a Carl Zeiss Microscope and processed using the software provided by the manufacturer.
Detection of Autophagy-Related Protein and Virus VP1 Protein by Western Blot
SH-SY5Y cells exposed to various conditions were washed twice with ice-cold PBS, then lysed with RIPA lysis buffer (Beyotime) containing 0.1% phenylmethylsulfonyl fluoride (PMSF, Beyotime), and centrifuged at 15,000 rpm for 10 min at 4 • C. The samples were subsequently boiled and denatured. Next, 30 µg of cell protein samples were subjected to 10%-12% SDS polyacrylamide gel electrophoresis after measuring the protein concentration using the BCA Protein Assay kit (Beyotime Institute of Biotechnology, Shanghai, China), and transferred to 0.22 µm PVDF membranes (Millipore) and then blocked with 5% non-fat milk for 1 h (room temperature). The membranes were incubated with the primary antibody at 4 • C overnight, and incubated with horseradish-peroxidase-conjugated Viruses 2020, 12, 11 5 of 14 secondary antibodies for 60 min followed by washing. Finally, protein bands were detected using the ultra-sensitive multi-function imager.
Results
Construction and Rescue of Recombinant Virus SDLY107-VP1
We compared the VP1 amino acid sequences of the SDLY107 and SDJN2015-01 strains, and the results are shown in Figure 1A . There were differences between the 146th (V→I) and 147th (V→A) amino acids of SDLY107 and SDJN2015-01. To explore the role of VP1 mutations in EV71 replication, a recombinant virus replacing the VP1 full-length fragment was constructed and rescued. The construction schematic diagram of SDLY107-VP1 is shown in Figure 1B -D. The VP1 upstream and downstream fragments of the SDLY107 strain and the VP1 fragment of the SDJN2015-01 strain were obtained by PCR reaction (Figure 2A ). The recombinant DNA fragments were obtained by fusion PCR using the three DNA fragments as templates ( Figure 2B ), and linked to the pMD-19T vector for blue and white spot screening. The pMD-19T plasmid containing the recombinant DNA fragment and the full-length pMD-19T-107 plasmid were identified by double digestion with restriction endonucleases Nru I and BsiW I ( Figure 2C ). The DNA fragments containing the VP1 sequence of the SDJN2015-01 strain were recovered and the remaining fragments of the VP1 sequence of the SDLY107 strain were removed. The recovered products were transformed after T4 connection, and the recombinant plasmid pMD-19T-107-VP1 was successfully obtained and digested by restriction endonuclease XbaI and Hind III. The full-length DNA fragment of SDLY107-VP1 was recovered ( Figure 2D ) and transcribed in vitro to obtain the RNA of the recombinant virus SDLY107-VP1.The SDLY107 strain and the SDLY107-VP1 strain were all identical except for the VP1 gene. We compared the VP1 amino acid sequences of the SDLY107 and SDJN2015-01 strains, and the results are shown in Figure 1A . There were differences between the 146th (V→I) and 147th (V→A) amino acids of SDLY107 and SDJN2015-01. To explore the role of VP1 mutations in EV71 replication, a recombinant virus replacing the VP1 full-length fragment was constructed and rescued. The construction schematic diagram of SDLY107-VP1 is shown in Figure 1B -D. The VP1 upstream and downstream fragments of the SDLY107 strain and the VP1 fragment of the SDJN2015-01 strain were obtained by PCR reaction (Figure 2A ). The recombinant DNA fragments were obtained by fusion PCR using the three DNA fragments as templates ( Figure 2B ), and linked to the pMD-19T vector for blue and white spot screening. The pMD-19T plasmid containing the recombinant DNA fragment and the full-length pMD-19T-107 plasmid were identified by double digestion with restriction endonucleases Nru I and BsiW I ( Figure 2C ). The DNA fragments containing the VP1 sequence of the SDJN2015-01 strain were recovered and the remaining fragments of the VP1 sequence of the SDLY107 strain were removed. The recovered products were transformed after T4 connection, and the recombinant plasmid pMD-19T-107-VP1 was successfully obtained and digested by restriction endonuclease XbaI and Hind III. The full-length DNA fragment of SDLY107-VP1 was recovered ( Figure 2D ) and transcribed in vitro to obtain the RNA of the recombinant virus SDLY107-VP1.The SDLY107 strain and the SDLY107-VP1 strain were all identical except for the VP1 gene. 
Recombinant Virus Biological Characteristics
SH-SY5Y cells and RD cells were infected with the SDLY107 strain, SDLY107-VP1 strain, and SDJN2015-01 strain. Virus replication curves were analyzed by detecting the total viral RNA. There were no significant differences among the replication curves of the three strains of virus in RD cells ( Figure 3A ). However, the replication power of the recombinant virus SDLY107-VP1 was significantly weaker than that of the parent strain SDLY107, especially between 24 h and 84 h ( Figure  3B ). Replacement of VP1 gene was concluded to reduce viral replication in neurons. Changes in amino acids 146 and 147 were related to the neurovirulence of the virus. SH-SY5Y cells were then infected with the three strains. The rate of cell injury was determined by LDH at 24 h after infection. The rate of cell injury of the recombinant virus SDLY107-VP1 was significantly weaker than that of the parent strain SDLY107 ( Figure 3C ); replacement of VP1 fragments attenuated the ability of virulent strains to cause cell injury. 
SH-SY5Y cells and RD cells were infected with the SDLY107 strain, SDLY107-VP1 strain, and SDJN2015-01 strain. Virus replication curves were analyzed by detecting the total viral RNA. There were no significant differences among the replication curves of the three strains of virus in RD cells ( Figure 3A ). However, the replication power of the recombinant virus SDLY107-VP1 was significantly weaker than that of the parent strain SDLY107, especially between 24 h and 84 h ( Figure 3B ). Replacement of VP1 gene was concluded to reduce viral replication in neurons. Changes in amino acids 146 and 147 were related to the neurovirulence of the virus. SH-SY5Y cells were then infected with the three strains. The rate of cell injury was determined by LDH at 24 h after infection. The rate of cell injury of the recombinant virus SDLY107-VP1 was significantly weaker than that of the parent strain SDLY107 ( Figure 3C ); replacement of VP1 fragments attenuated the ability of virulent strains to cause cell injury. 
Autophagic Flux in SH-SY5Y Cells Is Inhibited by EV71 VP1 Protein
To explore the mechanism by which the VP1 gene affects the replication ability of virus in nerve cells, autophagy, which has been proven to be related to viral replication, was quantitatively analyzed. SH-SY5Y cells were infected with the three strains. Cell lysates were collected at 6 h, 9 h, 12 h, and 24 h. Uninfected cells served as the sham control. LC3 and p62 were examined by western blot analysis. SDLY107 strain infection resulted in an increase in the LC3 and p62 content, but the SDJN2015-01 strain and SDLY107-VP1 strain did not cause significant changes in LC3 and p62 levels ( Figure 4A,C,D) . This indicated that SDLY107 could inhibit autophagic flux in SH-SY5Y cells. The SDLY107-VP1 and SDJN2015-01 strains did not have a significant impact on autophagic flux in SH-SY5Y cells. Figure 4B and 4E shows the fluorescent staining of autophagosomes in SH-SY5Y cells. The number of autophagosomes in SH-SY5Y cells infected with SDLY107 strain increased with the prolongation of infection time. However, the number of autophages did not increase significantly after infection with SDLY107-VP1 and SDJN2015-01 strains. This indicated that SDLY107 could lead to the accumulation of autophagosomes, which is beneficial for viral replication. The replacement of VP1 attenuated the inhibition of autophagic flow by virulent strains in SH-SY5Y cells. infected with the three strains at 24 h. The data represent means + SD from three experiments. *p < 0.05, **p < 0.001 compared with the SDLY107-VP1 treated group.
Autophagic Flux in SH-SY5Y Cells is Inhibited by EV71 VP1 Protein
To explore the mechanism by which the VP1 gene affects the replication ability of virus in nerve cells, autophagy, which has been proven to be related to viral replication, was quantitatively analyzed. SH-SY5Y cells were infected with the three strains. Cell lysates were collected at 6 h, 9 h, 12 h, and 24 h. Uninfected cells served as the sham control. LC3 and p62 were examined by western blot analysis. SDLY107 strain infection resulted in an increase in the LC3 and p62 content, but the SDJN2015-01 strain and SDLY107-VP1 strain did not cause significant changes in LC3 and p62 levels ( Figure 4A,C,D) . This indicated that SDLY107 could inhibit autophagic flux in SH-SY5Y cells. The SDLY107-VP1 and SDJN2015-01 strains did not have a significant impact on autophagic flux in SH-SY5Y cells. Figure 4B and 4E shows the fluorescent staining of autophagosomes in SH-SY5Y cells. The number of autophagosomes in SH-SY5Y cells infected with SDLY107 strain increased with the prolongation of infection time. However, the number of autophages did not increase significantly after infection with SDLY107-VP1 and SDJN2015-01 strains. This indicated that SDLY107 could lead to the accumulation of autophagosomes, which is beneficial for viral replication. The replacement of VP1 attenuated the inhibition of autophagic flow by virulent strains in SH-SY5Y cells. 
VP1 Protein Affects Virus Replication Associated with Cell Autophagy
We treated cells with 3-MA 50 μM, CQ 20 μM, and rapamycin10 nM, and the levels of p62 and LC3 in cells were measured after 24 h. The 3-MA caused an increase in intracellular p62 levels and a decrease in LC3 levels ( Figure 5A,B) . CQ led to an increase in intracellular p62 and LC3 levels ( Figure  5C ,D). However, rapamycin caused a decrease in intracellular p62 and LC3 levels ( Figure 5E ,F). Our results indicated that 3-MA can inhibit the formation of autophagosomes, CQ can inhibit autophagic flux and lead to the accumulation of autophagosomes, while rapamycin can promote anautophagic flux and accelerate the degradation of autophagosomes. In order to explore the relationship between autophagy and viral replication, SH-SY5Y cells were treated with 3-MA, CQ, and rapamycin for 2 h and then infected with SDLY107, SDLY107-VP1, and SDJN2015-01, respectively. Cell lysates were harvested after 24h. LC3, p62, and capsid protein VP1 levels were detected by western blot. The culture supernatant was collected after 24 h and subjected to plaque assay to determine the viral titer. After infection with SDLY107 and SDLY107-VP1, the virus content in cell and culture supernatants decreased, and the overall replication level of virus decreased in the rapamycin-treated group. In the 3-MA-treated group, the virus content in cells did not change significantly, but the virus content in culture supernatant decreased, and the overall replication level of the virus decreased. However, in the CQ-treated group, the virus content in cells and culture supernatant increased and the overall replication level of virus increased (Figure 6A,B) . Unfortunately, due to the weak replication ability of SDJN2015-01 in nerve cells, no obvious VP1 protein band was detected by western blotting except in the CQ treatment group, but the change of virus titer in the culture supernatant was the same as that of the other two viruses. The results showed that the accumulation of autophagosomes is beneficial to virus replication in SH-SY5Y cells. The replication ability of the SDLY107 strain was stronger than that of the replacement strain SDLY107-VP1 because the SDLY107 strain can lead to the accumulation of autophagosomes. The replacement of VP1 results in the loss of ability of virulent strain to inhibit autolysosome degradation. 
We treated cells with 3-MA 50 µM, CQ 20 µM, and rapamycin10 nM, and the levels of p62 and LC3 in cells were measured after 24 h. The 3-MA caused an increase in intracellular p62 levels and a decrease in LC3 levels (Figure 5A,B) . CQ led to an increase in intracellular p62 and LC3 levels ( Figure 5C,D) . However, rapamycin caused a decrease in intracellular p62 and LC3 levels ( Figure 5E ,F). Our results indicated that 3-MA can inhibit the formation of autophagosomes, CQ can inhibit autophagic flux and lead to the accumulation of autophagosomes, while rapamycin can promote anautophagic flux and accelerate the degradation of autophagosomes. In order to explore the relationship between autophagy and viral replication, SH-SY5Y cells were treated with 3-MA, CQ, and rapamycin for 2 h and then infected with SDLY107, SDLY107-VP1, and SDJN2015-01, respectively. Cell lysates were harvested after 24h. LC3, p62, and capsid protein VP1 levels were detected by western blot. The culture supernatant was collected after 24 h and subjected to plaque assay to determine the viral titer. After infection with SDLY107 and SDLY107-VP1, the virus content in cell and culture supernatants decreased, and the overall replication level of virus decreased in the rapamycin-treated group. In the 3-MA-treated group, the virus content in cells did not change significantly, but the virus content in culture supernatant decreased, and the overall replication level of the virus decreased. However, in the CQ-treated group, the virus content in cells and culture supernatant increased and the overall replication level of virus increased (Figure 6A,B) . Unfortunately, due to the weak replication ability of SDJN2015-01 in nerve cells, no obvious VP1 protein band was detected by western blotting except in the CQ treatment group, but the change of virus titer in the culture supernatant was the same as that of the other two viruses. The results showed that the accumulation of autophagosomes is beneficial to virus replication in SH-SY5Y cells. The replication ability of the SDLY107 strain was stronger than that of the replacement strain SDLY107-VP1 because the SDLY107 strain can lead to the accumulation of autophagosomes. The replacement of VP1 results in the loss of ability of virulent strain to inhibit autolysosome degradation. 
Autophagy Affects the Survival of Nerve Cells Infected with EV71
SH-SY5Y cells were treated with 3-MA, CQ, and rapamycin for 2 h and then infected with SDLY107, SDLY107-VP1, and SDJN2015-01, respectively. The rate of cell injury was detected by LDH at 24 h after infection. After infection with three strains, the rate of cell injury was higher in the CQtreated group than in the control group, whereas the effect of the rapamycin treatment was the opposite. The cell injury rate of the 3-MA treatment group was not significantly different from that of the control group ( Figure 6C ). This suggests that the accumulation of autophagosomes increased the cell injury rate. The difference of cell injury ability between the SDLY107 and SDLY107-VP1 strains in SH-SY5Y cells was related not only to viral replication but also to autophagy; the SDLY107 strain and the SDLY107-VP1 strain were identical except for the VP1 gene. Therefore, VP1 regulates viral replication and cell injury by affecting the accumulation of autophages. Figure 6 . (A) Intracellular VP1 protein content. SH-SY5Y cells were treated with 3-MA, CQ, or rapamycin for 2 h and then infected with SDLY107, SDLY107-VP1, and SDJN2015-01, respectively. Cell lysates were harvested after 24 h. LC3, p62, and capsid protein VP1 levels were detected by western blot. (B) Virus titer of culture supernatant. SH-SY5Y cells were treated with 3-MA, CQ, or rapamycin for 2 h and then infected with SDLY107, SDLY107-VP1, and SDJN2015-01, respectively. After 24 h, the cell culture supernatant was harvested and the culture supernatant titer was measured by plaque assay. (C) Effect of autophagy on cell injury. SH-SY5Y cells were treated with 3-MA, CQ, or rapamycin for 2 h and then infected with SDLY107, SDLY107-VP1, and SDJN2015-01, respectively. 
SH-SY5Y cells were treated with 3-MA, CQ, and rapamycin for 2 h and then infected with SDLY107, SDLY107-VP1, and SDJN2015-01, respectively. The rate of cell injury was detected by LDH at 24 h after infection. After infection with three strains, the rate of cell injury was higher in the CQ-treated group than in the control group, whereas the effect of the rapamycin treatment was the opposite. The cell injury rate of the 3-MA treatment group was not significantly different from that of the control group ( Figure 6C ). This suggests that the accumulation of autophagosomes increased the cell injury rate. The difference of cell injury ability between the SDLY107 and SDLY107-VP1 strains in SH-SY5Y cells was related not only to viral replication but also to autophagy; the SDLY107 strain and the SDLY107-VP1 strain were identical except for the VP1 gene. Therefore, VP1 regulates viral replication and cell injury by affecting the accumulation of autophages.
mTOR Is a Key Molecule Affecting EV71 Replication in Nerve Cells
mTOR signaling is generally involved in regulating cell survival, cell growth, cell metabolism, protein synthesis, and autophagy, as well as homeostasis [30] . SH-SY5Y cells were infected with the three strains, cell lysates were harvested, and mTOR/p-mTOR was detected by western blot. The SDLY107 strain significantly reduced p-mTOR content; however, no similar results were observed for the other two strains ( Figure 7A ). VP1 replacement attenuated the ability of virulent strains to inhibit mTOR phosphorylation, which is beneficial to autophagy. This autophagy facilitates the replication of virulent strains in nerve cells. VP1 affects virus replication via autophagy related to mTOR signaling molecules. We selected the SDLY107 strain to infect SH-SY5Y cells, and found by immunofluorescence test that EV71 virus and mTOR can co-locate ( Figure 7B ). This also indicates that there could be interaction between the EV71 virus and mTOR molecule. Subsequently, SH-SY5Y cells pre-treated with rapamycin (10 nM) were infected with SDLY107, and the viral capsid protein VP1 was examined by western blot and intracellular viruses were detected by immunofluorescent assay. The amount of total RNA and RNA in the cell culture supernatant was detected by real-time fluorescent quantitative PCR. Inhibition of mTOR by rapamycin, which can promote the degradation of autolysosomes, can restrain viral RNA synthesis and block viral protein VP1 expression caused by the SDLY107 infection ( Figure 7C-E 3.6. mTOR is a Key Molecule Affecting EV71 Replication in Nerve Cells mTOR signaling is generally involved in regulating cell survival, cell growth, cell metabolism, protein synthesis, and autophagy, as well as homeostasis [30] . SH-SY5Y cells were infected with the three strains, cell lysates were harvested, and mTOR/p-mTOR was detected by western blot. The SDLY107 strain significantly reduced p-mTOR content; however, no similar results were observed for the other two strains ( Figure 7A ). VP1 replacement attenuated the ability of virulent strains to inhibit mTOR phosphorylation, which is beneficial to autophagy. This autophagy facilitates the replication of virulent strains in nerve cells. VP1 affects virus replication via autophagy related to mTOR signaling molecules. We selected the SDLY107 strain to infect SH-SY5Y cells, and found by immunofluorescence test that EV71 virus and mTOR can co-locate ( Figure 7B ). This also indicates that there could be interaction between the EV71 virus and mTOR molecule. Subsequently, SH-SY5Y cells pre-treated with rapamycin (10 nM) were infected with SDLY107, and the viral capsid protein VP1 was examined by western blot and intracellular viruses were detected by immunofluorescent assay. The amount of total RNA and RNA in the cell culture supernatant was detected by real-time fluorescent quantitative PCR. Inhibition of mTOR by rapamycin, which can promote the degradation of autolysosomes, can restrain viral RNA synthesis and block viral protein VP1 expression caused by the SDLY107 infection ( Figure 7C -E). Figure 7 . (A) SH-SY5Y cells were infected with the three strains. Cell lysates were collected at 24 h. mTOR and p-mTOR levels were detected by western blot. (B) EV71 and mTOR were detected by colocalization immunofluorescence at 24 h after infection. FICT stained EV71 green, TRITC stained mTOR red, and DAPI stained nucleus blue. (C) SH-SY5Y cells were seeded on a six well plate and exposed to rapamycin or not before being infected with EV71. The viral VP1 protein was examined by western blot after 24 h. (D) SH-SY5Y cells were inoculated into a 12 well plate with about 2 × 10 5 cells per well and exposed to rapamycin or not before being infected with EV71. Immunofluorescent assay was used to detect the intracellular virus content after 24 h. (E) SH-SY5Y cells were inoculated onto a 12 well plate and exposed to rapamycin or not before being infected with EV71, and the amount of viral RNA was measured by real-time fluorescent quantitative PCR after 24 h. Rapa stands for rapamycin. The data represent means + SD from three experiments, **p < 0.001, compared with the rapamycin treatment group.
Figure 7.
(A) SH-SY5Y cells were infected with the three strains. Cell lysates were collected at 24 h. mTOR and p-mTOR levels were detected by western blot. (B) EV71 and mTOR were detected by co-localization immunofluorescence at 24 h after infection. FICT stained EV71 green, TRITC stained mTOR red, and DAPI stained nucleus blue. (C) SH-SY5Y cells were seeded on a six well plate and exposed to rapamycin or not before being infected with EV71. The viral VP1 protein was examined by western blot after 24 h. (D) SH-SY5Y cells were inoculated into a 12 well plate with about 2 × 10 5 cells per well and exposed to rapamycin or not before being infected with EV71. Immunofluorescent assay was used to detect the intracellular virus content after 24 h. (E) SH-SY5Y cells were inoculated onto a 12 well plate and exposed to rapamycin or not before being infected with EV71, and the amount of viral RNA was measured by real-time fluorescent quantitative PCR after 24 h. Rapa stands for rapamycin. The data represent means + SD from three experiments, ** p < 0.001, compared with the rapamycin treatment group.
Discussion
A number of virulence determinants for EV71 have been reported, which may influence virus assembly, attachment, replication, or cell tropism. However, the mechanism by which VP1 affects viral replication and virulence has not been elucidated. In this study, a recombinant virus with the VP1 fragment replaced was successfully constructed. The SDLY107 strain and the SDLY107-VP1 strain were identical except for the VP1 gene. Replacement of the VP1 fragment altered viral replication. Increased replication capacities of EV71 strains have previously been associated with increased disease severity in animal models, and positive correlations have been found between virus titers in the respiratory tract and disease severity in humans [29, 31, 32] . Therefore, the VP1 protein is closely related to the virulence and pathogenicity of the virus. A variety of viruses can manipulate autophagy to assist their replication [33] . Autophagy is induced in host cells by viruses, including human cytomegalovirus, hepatitis C virus, herpes simplex virus-1, CVB3, influenza A virus, HIV-I, and EV71 [34] [35] [36] [37] [38] [39] [40] . EV71 replication induced the formation of autophagosomes and increased disease severity and viral titer [41] . Virus-containing autophagic vacuoles were isolated from the culture supernatant which suggests that autophagy contributed to the release and spread of the virus [20] . Our research demonstrated that SDLY107could inhibit autophagic flux in SH-SY5Y cells and lead to the accumulation of autophagosomes. However, replacement of VP1 directly led to decreased autophagosome accumulation and reduced viral replication. The accumulation of autophagosomes is beneficial to virus replication.
In this study, the viral titer and the rate of cell injury were decreased when autophagic flux was promoted by rapamycin ( Figure 6 ). Host defense is another important role of autophagy in addition to maintaining cell homeostasis. Autophagy improves host defense mechanisms through several biological functions [42] [43] [44] . The role of autophagy for host defense against viruses strongly depends on the type of infection and involves several mechanisms, especially those involved in autophagosome generation and maturation. RNA viruses seem to stabilize autophagosomes by preventing their degradation. The human immunodeficiency virus type-1 (HIV) blocks autophagosome maturation in infected macrophages [45] . The degradation of autophagosomes and the elimination of the invading pathogens are accelerated when autophagy induced by a virus is promoted. Therefore, the virus titer and cell injury rate were reduced after treatment with rapamycin, but the opposite result was obtained when autophagosome degradation was inhibited ( Figure 6 ).
Although EV71 infection can induce autophagy in vivo or in vitro, its exact mechanism is unclear. The PI3K/Akt/mTOR pathway plays a vital role in the regulation of autophagy, and suppressing mTOR activity leads to the initiation of autophagy and the formation of autophagosomes [46] . This study demonstrated that VP1 replacement attenuates the ability of virulent strains to inhibit mTOR phosphorylation, which is beneficial to autophagy. The formation and accumulation of autophagosomes are beneficial to the replication of the virulent strains in nerve cells. However, inhibition of mTOR activation not only leads to the initiation of autophagy and the formation of autophagosomes, but also promotes the degradation of autolysosomes. The cell injury rate, intracellular viral VP1 protein content, and culture supernatant titer were reduced after cells were treated with rapamycin, which could promote the degradation of autolysosomes. The synthesis of viral RNA was inhibited by rapamycin.
In summary, the study demonstrated that replacement of EV71 VP1 resulted in decreased replication of EV71 in SH-SY5Y cells by affecting cell autophagy via the mTOR pathway. The synthesis of viral RNA was inhibited by rapamycin, which inhibits mTOR and promotes the degradation of autolysosomes. The study provides new insights into the molecular mechanism of EV71 and EV71-related HFMD. 
